Comparison

Talazoparib European Partner

Item no. TMO-T6253-1mg
Manufacturer TargetMol
CASRN 1207456-01-6
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9985
Citations 1. Wang B, et al. Molecular Cancer Therapeutics, 2009, 8 (12 Suppl), A121.
Smiles Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias LT-673,BMN-673
Shipping Condition Cool pack
Available
Manufacturer - Targets
PARP
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
380.35
Description
Talazoparib (LT-673) is a new-type PARP inhibitor (IC50: 0.58 nM), It similarly binds to PARP1/2 (Kis: 1.2/0.85 nM).
Pathways
Chromatin/Epigenetic|||DNA Damage/DNA Repair
Bioactivity
Talazoparib(IC50=0.58 nM), a new-type PARP inhibitor, effectively inhibits PARP-2, and is very sensitive to PTEN mutation. Talazoparibbut does not inhibit PARG.
Receptor
PARP

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close